JazzPharmaceuticals Innovation that performs
About JazzPharmaceuticals
New Products
Our Products
News & Meetings
Partnering
Investors
Careers
Contact Us
Product Reimbursement Assistance
  Xyrem
  Antizol
Product Reimbursement Assistance
News & Meetings

07/16/2008 | Press Release
JAZZ PHARMACEUTICALS ANNOUNCES $26.0 MILLION REGISTERED DIRECT OFFERING

06/11/2008 | Press Release
JAZZ PHARMACEUTICALS FILES FORM S-3 REGISTRATION STATEMENTS

06/11/2008 | Press Release
JAZZ PHARMACEUTICALS ANNOUNCES DEVELOPMENT TIMELINE UPDATES

06/02/2008 | Press Release
JAZZ PHARMACEUTICALS, INC. COMPLETES ENROLLMENT IN FIRST OF TWO PHASE III CLINICAL TRIALS OF SODIUM OXYBATE TO TREAT FIBROMYALGIA

05/13/2008 | Press Release
JAZZ PHARMACEUTICALS, INC. ANNOUNCES FIRST QUARTER 2008 FINANCIAL RESULTS

05/09/2008 | Press Release
JAZZ PHARMACEUTICALS TO PRESENT AT CITIGROUP HEALTHCARE FORUM

05/08/2008 | Press Release
JAZZ PHARMACEUTICALS, INC. SECURES $75 MILLION COMMITTED EQUITY FINANCING FACILITY

05/07/2008 | Press Release
JAZZ PHARMACEUTICALS, INC. TO ANNOUNCE FIRST QUARTER RESULTS ON MAY 13, 2008

04/23/2008 | Press Release
JAZZ PHARMACEUTICALS TO PRESENT AT MORGAN STANLEY CONFERENCE

04/14/2008 | Press Release
JAZZ PHARMACEUTICALS' LUVOX CR IS NOW AVAILABLE FOR PATIENTS WITH SOCIAL ANXIETY DISORDER (SAD) AND OBSESSIVE COMPULSIVE DISORDER (OCD)



Join the Team

Take a look at the current career opportunities available at Jazz Pharmaceuticals and apply online.
Apply


Product Reimbursement Assistance
View Printer Friendly Version of That Page
Jazz Pharmaceuticals offers support and guidance on reimbursement through our Patient Affairs area to patients and providers for our chronic, patient-administered products, as we understand the challenges you may be facing in obtaining your product and/or insurance coverage.

Patient Assistance Programs
Jazz Pharmaceuticals currently provides Patient Assistance Programs on Xyrem for U.S. patients who are uninsured and/or underinsured, through the National Organization of Rare Disorders, Inc. (NORD), a non-profit organization dedicated to the identification, treatment and cure of rare “orphan diseases."

Xyrem® (sodium oxybate) oral solution:
Reimbursement assistance is available through the Xyrem Success Program® for registered patients. Please call 1-866-XYREM88 (1-866-997-3688) or visit the www.xyrem.com website for more information.

To request an application for Xyrem, please contact the Xyrem Success Program at 1-866-XYREM88 (1-866-997-3688).





© 2008 Jazz Pharmaceuticals, Inc. : Privacy Policy & Terms of Use
About Us : Our Products : News & Meetings : Partnering : Investors : Careers : Contact Us : Site Map : Product Reimbursement Assistance